The appointment comes at a critical time for the national peak body, it said, which represents more than seven million Australians living with arthritis and musculoskeletal conditions.
Arthritis Australia appoints Louise Hardy as CEO at pivotal moment for national advocacy
February 2, 2026 Latest NewsBioPharmaBioPharmaDispatch Executive
Latest Video
New Stories
-
Arthritis Australia appoints Louise Hardy as CEO at pivotal moment for national advocacy
February 2, 2026 - - Latest News -
AusBiotech urges adoption of national life sciences strategy as global competition intensifies
February 2, 2026 - - Australian Biotech -
Cyclopharm delivers record revenue as US emerges as growth engine
February 2, 2026 - - Australian Biotech -
Sandoz adds to vision care options with the listing of biosimilar
February 2, 2026 - - Latest News -
PYC’s capital raise marks one of the largest biotech fundraisings in Australian market history
February 2, 2026 - - Australian Biotech -
Genetic Signatures appoints seasoned life sciences executive as CEO
February 2, 2026 - - Australian Biotech -
EMA decision clears regulatory path for Argenica’s lead stroke drug in Europe
February 2, 2026 - - Australian Biotech

